Sleep Medicine Reviews
Volume 6, Issue 4 , Pages 321-332, July 2002

Adenosine and sleep

Institute of Biomedicine, Department of Physiology, Biomedicum, Helsinki

Abstract 

Adenosine is directly linked to the energy metabolism of cells. In the central nervous system an increase in neuronal activity enhances energy consumption as well as extracellular adenosine concentrations. In most brain areas high extracellular adenosine concentrations, through A1 adenosine receptors, decrease neuronal activity and thus the need for energy. Adenosine seems to act as a direct negative feed-back inhibitor of neuronal activity. Hypoxia and ischemia induce very high extracellular adenosine levels, which may limit further brain damage. In brain areas that regulate cortical vigilance, particularly in the basal forebrain, high extracellular adenosine concentrations, induced by prolonged wakefulness, decrease the activity of presumably cholinergic cells and via this mechanism promote sleep. Our hypothesis is that in the cholinergic basal forebrain prolonged wakefulness induces local energy depletion that generates increases in extracellular adenosine concentrations in this area.

In addition to the immediate effects, high extracellular adenosine concentrations also induce intracellular changes in signal transduction and transcription, e.g. increase in A1 receptor expression and NF-κB binding activity. These changes may at least partially mediate the long term effects of prolonged wakefulness. Adenosine may also be a common mediator of the effects of several other sleep-inducing factors.

Keywords: adenosine, caffeine, c-fos, energy metabolism, NF-κB sleep, sleep deprivation

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence should be addressed to: Tarja Porkka-Heiskanen, Institute of Biomedicine, Department of Physiology, Biomedicum Helsinki, PO Box 63, 00014 University of Helsinki, Helsinki, Finland. Tel.: 191 25 317; Fax: 191 25 302; E-mail:porkka@cc.helsinki.fi

PII: S1087-0792(01)90201-1

doi:10.1053/smrv.2001.0201

Sleep Medicine Reviews
Volume 6, Issue 4 , Pages 321-332, July 2002